Rocket Pharmaceuticals Cash Flow Statement (2016-2025) | RCKT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	-40.04M	-33.80M	-49.37M	-43.95M	-42.41M	-54.01M	-57.60M	-68.30M	-60.75M	-68.38M	-64.18M	-62.94M	-64.82M	-71.89M	-68.57M	-61.55M	-63.52M	-71.14M	-52.01M	-43.75M
Depreciation and Depletion (Quarter)			0.80M		0.77M	1.00M	1.10M	-2.10M	1.14M	1.20M	1.20M
Share-based Compensation (Quarter)	7.90M	7.31M	6.99M	7.04M	6.27M	7.37M	7.68M	9.69M	8.91M	10.24M	10.32M	9.93M	10.25M	11.33M	11.25M	11.09M	10.33M	10.86M	9.76M	6.11M
Gains from Sales and Divestitures (Quarter)						0.01M		0.04M	0.13M	0.13M	0.30M	0.13M						0.48M		0.94M
Gains from Investment Securities (Quarter)		0.00M	0.02M	5.22M	0.47M	12.53M	0.02M	0.05M	0.76M	14.88M	14.89M	-2.38M	1.11M	0.12M	0.20M	-0.00M		16.36M	5.62M
Asset Writedowns and Impairment (Quarter)
Non-cash Items (Quarter)	349.41M	346.48M	203.78M	128.82M	84.96M	72.72M	88.46M	118.77M	97.26M	120.47M	127.12M	250.60M	208.60M	136.37M	104.70M	63.30M	30.67M	6.45M	9.94M	0.71M
Cash from Operations (Quarter)	-24.28M	-38.53M	-27.41M	-30.94M	-39.22M	-39.04M	-43.86M	-56.02M	-57.56M	-50.87M	-57.15M	-29.34M	-56.86M	-53.82M	-52.10M	-46.94M	-55.79M	-48.96M	-50.42M	-34.84M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	0.59M	-0.73M	-0.74M	0.75M	-0.58M	-0.40M	-0.16M	1.08M	2.42M	2.68M	2.28M	3.27M	2.76M	2.24M	1.85M	1.22M	2.19M	2.22M	1.68M	1.21M
Depreciation & Amortization (CF) (Quarter)	0.67M	0.70M	0.80M	1.05M	0.77M	1.00M	1.10M	-2.10M	1.14M	1.19M	1.22M	1.40M	1.72M	1.83M	1.85M	1.82M	2.45M	2.04M	2.70M	1.68M
Change in Working Capital
Change in Account Payables (Quarter)
Change in Accured Expenses (Quarter)	7.05M	-7.08M	-2.81M	2.79M	-0.01M	-0.01M	7.22M	2.48M	-7.75M	3.27M	-1.13M	6.32M	-2.14M	4.26M	-2.04M	5.99M	-5.26M	8.12M	-2.94M	-0.00M
Investing Activities
Capital Expenditures (Quarter)	0.33M	1.45M	3.88M	1.97M	1.96M	2.90M	0.50M	-3.26M	1.79M	5.34M	4.66M	-10.71M	2.04M	1.93M	-3.70M	-0.08M	0.36M	0.05M	-0.05M	-0.36M
Sales of Property, Plant and Equipment (Quarter)
Acquisitions (Quarter)
Change in Acquisitions & Divestments (Quarter)	74.97M	105.61M	53.56M	38.30M	81.98M	81.69M	58.41M	50.82M	62.34M	108.25M	66.40M	72.34M	101.02M	96.13M	99.83M	86.48M	82.26M	84.50M	123.00M	91.00M
Cash from Investing Activities (Quarter)	-29.17M	49.35M	-18.19M	16.86M	-62.99M	78.79M	23.46M	-108.58M	-36.72M	31.21M	48.25M	-140.81M	35.03M	55.62M	78.92M	-37.87M	-58.03M	31.76M	93.62M	36.42M
Financing Activities
Other financing activities (Quarter)
Change in Capital Stock
Shares Issued (Quarter)	8.79M	1.11M	-9.91M	11.33M					0.01M		0.05M	-0.05M	1.18M	1.53M	0.18M	0.32M
Shares Repurchased (Quarter)
Preferred Shares Issued (Quarter)
Misc.
Cash from Financing Activities (Quarter)	8.79M	1.11M	26.64M	1.14M	0.08M	17.25M	29.53M	108.44M	18.34M	0.18M	189.49M	0.39M	1.18M	1.53M	0.18M	182.85M		0.21M	-0.07M
Change in Cash (Quarter)	-44.66M	11.94M	-18.96M	-12.94M	-102.14M	57.00M	9.13M	-56.17M	-75.94M	-19.48M	180.59M	-169.75M	-20.64M	3.33M	26.99M	98.04M	-113.83M	-16.99M	43.13M	1.58M
Free Cash Flow (Quarter)	-24.61M	-39.97M	-31.29M	-32.91M	-41.18M	-41.94M	-44.36M	-52.76M	-59.35M	-56.21M	-61.80M	-18.63M	-58.89M	-55.75M	-48.40M	-46.86M	-56.15M	-49.01M	-50.37M	-34.48M
Net Cash Flow (Quarter)	-44.66M	11.94M	-18.96M	-12.94M	-102.14M	57.00M	9.13M	-56.17M	-75.94M	-19.48M	180.59M	-169.75M	-20.64M	3.33M	26.99M	98.04M	-113.83M	-16.99M	43.13M	1.58M

Research Tools

Rocket Pharmaceuticals Cash Flow Statement (2016-2025) | RCKT

Create an account

Sign In

Reset Password